D. Slebos (Groningen, Netherlands), A. Valipour (Wien, Austria), M. Schuhmann (Heidelberg, Germany), D. Gompelmann (Heidelberg, Germany)
Endoscopic valve removal >180 days since implantation in patients with severe emphysema
D. Gompelmann (Heidelberg, Germany)
|  |
Low flow phenotype during Chartis assessment: correlation with fissure integrity
R. Huebner (Berlin, Germany)
| |
Role of pulmonary rehabilitation after bronchoscopic treatment of emphysema
L. Bianchi (Lumezzane (Brescia), Italy)
| |
Comparative efficacy and safety of surgical and bronchoscopic approaches to lung volume reduction
W. Bulman (New York, United States of America)
| |
Ability for dynamic hyperinflation increases after bronchoscopic lung volume reduction in patients with severe emphysema.
K. Klooster (Groningen, Netherlands)
| |
Patient-specific goals significantly improve after endobronchial coil treatment in emphysema
J. Hartman (Groningen, Netherlands)
| |
The effect of endobronchial valves on body composition in patients with advanced emphysema
K. Sanders (Maastricht, Netherlands)
| |
Impact of lung volume reduction coils on patient´s physical activity
C. Pizarro (BONN, Germany)
| |
Clinical and quantitative CT (QCT) predictors of response to lung volume reduction treatment using coils (LVRC)
K. Kontogianni (Heidelberg, Germany)
|  |
New bacterial growth in bronchial secretions after bronchoscopic valve implantation
N. Sarmand (Heidelberg , Germany)
| |
CT derived emphysema sub-lobar phenotype distribution: perspectives for endoscopic approach
D. Oliveira (PORTO ALEGRE/ RS, Brazil)
| |
Development of bulla in the ipsilateral untreated lobe following Endoscopic Lung Volume Reduction (ELVR) with valves
J. Winantea (ESSEN, Germany)
| |
The effect of bronchoscopic lung volume reduction treatment on pulmonary ventilation and perfusion: comparison of valve and coil methods
Y. Intepe (Yozgat-Merkez, Turkey)
| |
Interventional endobronchial valve placement in major hemoptysis – a case series
K. Jahn (Basel, Switzerland)
| |
Targeted Lung Denervation improves COPD symptoms and health related quality of life at 6-months
D. Slebos (Groningen, Netherlands)
| |
Improved pulmonary resistance in healthy sheep following Targeted lung denervation (TLD)
P. Johnson (Plymouth, United States of America)
| |
Demonstration of pulmonary denervation using the Hering-Breuer reflex following Targeted lung denervation (TLD)
P. Johnson (Plymouth, United States of America)
| |
Targeted lung denervation; an evaluation of power dose effect
P. Johnson (Plymouth, United States of America)
| |